Persistent accumulation of misfolded proteins causes endoplasmic reticulum (ER) stress, a prominent feature in many neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). Here we report the identification of homeodomain interacting protein kinase 2 (HIPK2) as the essential link that promotes ER-stress-induced cell death via the IRE1a-ASK1-JNK pathway. ER stress, induced by tunicamycin or SOD1 G93A , activates HIPK2 by phosphorylating highly conserved serine and threonine residues (S359/T360) within the activation loop of the HIPK2 kinase domain. In SOD1 G93A mice, loss of HIPK2 delays disease onset, reduces cell death in spinal motor neurons, mitigates glial pathology, and improves survival. Remarkably, HIPK2 activation positively correlates with TDP-43 proteinopathy in NEFH-tTA/tetO-hTDP-43DNLS mice, sporadic ALS and C9ORF72 ALS, and blocking HIPK2 kinase activity protects motor neurons from TDP-43 cytotoxicity. These results reveal a previously unrecognized role of HIPK2 activation in ER-stress-mediated neurodegeneration and its potential role as a biomarker and therapeutic target for ALS.
Correspondence eric.huang2@ucsf.edu
In Brief Lee et al. identify HIPK2 (homeodomain interacting protein kinase 2) as an essential link that promotes ER-stressinduced cell death. Accumulation of misfolded SOD1 and TDP-43 proteins activates HIPK2, whereas deletion or pharmacological inhibition of HIPK2 mitigates neurodegeneration.
INTRODUCTION
An important hallmark of neurodegenerative diseases is the accumulation of abnormally folded proteins that lead to neuronal dysfunction and cell death. Accumulation of misfolded proteins in the endoplasmic reticulum (ER) activates highly conserved signal transduction pathways collectively known as the unfolded protein response (UPR). Under ER stress, UPR upregulates genes to assist in protein folding and degradation; however, prolonged ER stress can activate irreversible signaling pathways leading to cell death (Kim et al., 2008; Oakes and Papa, 2015) . Several lines of evidence indicate that ER stress plays a critical role in the pathogenesis of amyotrophic lateral sclerosis (ALS), an adult-onset neurodegenerative disease that affects upper and lower motor neurons (Boillé e et al., 2006; Pasinelli and Brown, 2006) . The discovery of genetic mutations in familial ALS (FALS) reveals novel mechanisms that are causally linked to disease pathogenesis. Among the ''ALS disease genes,'' four account for the majority of FALS cases, including SOD1, , FUS/TLS (fused in sarcoma/translocation in liposarcoma or FUS), and GGGGCC hexanucleotide expansions in C9ORF72 gene. Characterizations of these mutations suggest that dysfunctions in RNA metabolism and protein homeostasis via the ubiquitin-proteasome pathways might contribute to pathogenesis and disease progression in ALS (Lee et al., 2012; Ling et al., 2013) .
Several studies have investigated ER stress in relationship to neurodegeneration in ALS. For instance, misfolded mutant SOD1 protein has a high propensity to form insoluble aggregates in neuronal cytoplasm, where they trigger ER stress, disrupt axonal transport, and increase mitochondrial damage (Atkin et al., 2006; Bruijn et al., 1998; Israelson et al., 2010; Kiskinis et al., 2014) . Furthermore, emerging evidence indicates that the hexanucleotide expansion in C9ORF72 gene can generate non-ATG-initiated translation (RAN) dipeptides, which increases ER-stress-induced cell death (Almeida et al., 2013; Ash et al., 2013; Donnelly et al., 2013; Mori et al., 2013) . Finally, all C9ORF72-ALS (C9-ALS) patients and >95% SALS patients show TDP-43 proteinopathy characterized by cytoplasmic accumulations of ubiquitinated and phosphorylated TDP-43 protein aggregates in neurons and glia (Arai et al., 2006; Neumann et al., 2006) . Consistent with these results, ER stress has been reported in the spinal cord tissues of SALS patients (Atkin et al., 2008) . These results underscore the critical role of ER stress activation as an important mechanism that contributes to pathogenesis and disease progression in FALS and SALS.
Despite these findings, it remains unclear how misfolded proteins promote neurodegeneration. There are three major downstream targets of ER stress response, including two protein kinases IRE1a (inositol requiring enzyme 1a) and PERK (eukaryotic translation initiation factor 2 alpha kinase), and a transmembrane transcription factor ATF6 (Kim et al., 2008; Ron and Walter, 2007) . The presence of misfolded proteins activates these downstream targets to promote adaptive ER stress response and increase protein folding capacity by transcriptionally upregulating chaperones to unfold the misfolded proteins and restore ER homeostasis. However, when the accumulation of misfolded proteins becomes chronic and overwhelming, ER stress can activate destructive signaling pathways to promote cell death (Lin et al., 2007) . Several groups have shown that activation of PERK correlates with disease progression in the mutant SOD1 model of ALS (Hetz et al., 2009; Kikuchi et al., 2006; Saxena et al., 2009; Wang et al., 2011) . For instance, activation of PERK has been identified in a subset of motor neurons that are vulnerable to misfolded SOD1 G93A proteins (Saxena et al., 2009) . Interestingly, haploinsufficiency of PERK causes an accelerated disease onset and shortens lifespan in SOD1
G85R
mice, suggesting that PERK activation may protect against SOD1 G85R -induced neurodegeneration (Wang et al., 2011) .
Unlike PERK, much less is known about the role of IRE1a in ER-stress-mediated neurodegeneration. IRE1a is an ER transmembrane protein that possesses both kinase and endoribonuclease (RNase) properties. Upon ER stress, the luminal domain of IRE1a detects the presence of unfolded proteins, causes IRE1a to oligomerize, and trans-phosphorylates the kinase domain of IRE1a. IRE1a kinase activates its RNase activity to promote X-Binding Protein (Xbp1) mRNA splicing and upregulation of genes important for protein quality control and microRNAs that regulate apoptosis (Calfon et al., 2002; Han et al., 2009; Yoshida et al., 2001 ). In addition, activation of IRE1a can promote apoptosis signal-regulating kinase 1 (ASK1) and JNK-dependent cell death (Nishitoh et al., 2008; Ron and Walter, 2007) . However, the mechanism that connects these IRE1a downstream targets to neurodegeneration remains poorly characterized.
Here we show that homeodomain interacting protein kinase 2 (HIPK2), previously implicated in developmental programmed cell death (Wiggins et al., 2004; Zhang et al., 2007) , is an essential link that connects the IRE1a pathway to JNK activation and neuronal cell death during persistent and irreversible ER stress. HIPK2 activation precedes disease onset in SOD1 G93A and NEFH-tTA/tetO-hTDP-43DNLS mice, and loss of HIPK2 reduces apoptosis in spinal motor neurons, mitigates glial pathology, and improves survival in SOD1 G93A mice. Furthermore, HIPK2 activation positively correlates with TDP-43 proteinopathy in SALS and C9-ALS, while blocking HIPK2 kinase activity protects motor neurons from TDP-43 cytotoxicity. These results reveal a previously unrecognized role of HIPK2 in protein misfolding-mediated neurodegeneration and its potential role as a biomarker and therapeutic target for ALS. MEFs showed considerable resistance to tunicamycin-induced ER-stress-related cell death detected by either the tetrazolium dye MTT or by the release of lactate dehydrogenase (LDH) (Figures S1C and S1D) . Similarly, Hipk2 À/À MEFs were resistant to ER stress induced by brefeldin A (BFA), which blocks Golgi trafficking by inhibiting small GTP-binding protein ADP ribosylation factor ( Figure S1E ). Finally, HEK293 cells treated with Hipk2 siRNA, but not control siRNA, also showed resistance to tunicamycin toxicity, whereas overexpression of HIPK2 restored the sensitivity to tunicamycin ( Figure S1F ). To determine if loss of HIPK2 would similarly protect neurons from ER-stress-induced cell death, we adopted an in vivo ER stress model using a single intraperitoneal injection of tunicamycin (1 mg/kg) in 3-month-old wild-type and Hipk2 À/À mice. Four days after the injection, brains and spinal cords from these mice were collected for histological analyses. Consistent with the results in MEFs, tunicamycin induced a marked increase of cell death in cortical neurons in wild-type mice, detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), progressive increase in activated caspase 3, and $30% reduction in NeuN+ cortical neurons ( Figures 1A-1F , 1M, 1N, and 1Y). In contrast, the same treatment caused fewer apoptotic neurons in Hipk2 À/À mutants, with no reduction in NeuN+ neuron number ( Figures 1G-1N ). The protective effects of HIPK2 lossof-function could also be detected in the spinal motor neurons, where Hipk2 À/À mutants showed significantly fewer TUNEL+ spinal motor neurons and better preservation of neuron numbers ( Figures 1O-1X ). Consistent with these data, cultured cortical neurons from embryonic day 15.5 (E15.5) Hipk2 À/À mutants were more resistant to tunicamycin-induced cell death, characterized by the reduced number of activated caspase 3+ neurons ( Figures S2A-S2I ). Conversely, overexpressing HIPK2 in wildtype cortical neurons enhanced tunicamycin-induced cell death ( Figures S2J-S2S ). These results show that HIPK2 is necessary and sufficient to promote cell death during ER stress. Among the three distinct signaling pathways downstream of ER stress, IRE1a is known to promote Xbp1 splicing, which converts XBP1 into a functionally active transcription factor that activates target genes to reduce ER stress response (Ron and Walter, 2007) . If ER stress persists, prolonged activation of IRE1a irreversibly alters cell fate and activates cell death through ASK1-and JNK-dependent mechanisms that are poorly characterized. Since previous results indicate that HIPK2 can interact with JNK (Hofmann et al., 2003) , we asked whether loss of HIPK2 might affect tunicamycin-induced activation of IRE1a, ASK1, and JNK. Using phosphorylation-specific antibodies for activated IRE1a, ASK1, and JNK, we observed that tunicamyin treatment induced IRE1a and ASK1 activation and progressive increase in activated caspase 3 in wild-type brain tissues preceding JNK activation ( Figure 1Y ). Interestingly, loss of HIPK2 almost completely blocked caspase 3 cleavage and JNK activation in Hipk2 À/À brain tissues without affecting IRE1a or ASK1 activation or Xbp1 mRNA splicing ( Figure 1Z ). These results support the specific role of HIPK2 in promoting JNK activation under tunicamycin-induced ER stress.
RESULTS

HIPK2
ER Stress Promotes HIPK2 Activation via Site-Specific Phosphorylation
To investigate the role of HIPK2 in ER stress, we used in vitro kinase assays and mass spectrometry to determine whether tunicamycin-induced ER stress activates HIPK2 by phosphorylating a specific amino acid(s) within the activation loop of HIPK2 ( Figure 2A ) (Shang et al., 2013) . Consistent with the results in Figure 1 , tunicamycin induced sequential phosphorylation of ASK1, HIPK2, and JNK in HEK293 cells, with HIPK2 phosphorylation, shown by the incorporation of g-P 32 -ATP, occurring after ASK1 and before JNK activation ( Figures 2B and 2C ). To further identify specific amino acids in HIPK2 that become phosphorylated by ER stress, we expressed GFP-tagged HIPK2 in HEK293 cells, immunoprecipitated GFP-HIPK2 with magnetic beads conjugated with anti-GFP antibody, performed on-bead digestion with trypsin, and analyzed the samples using liquid chromatography-tandem mass spectrometry (LC-MS/MS). In these experiments, we consistently observed mixed spectra with strong evidence of phosphorylation at either T360 or Y361 site ( Figure 2D ), suggesting that the phosphorylation at these two sites was mutually exclusive. Consistent with the western blot data, quantitation of MS peak intensities showed that tunicamycin treatment produced a similar increase in phosphorylation at both sites ( Figure 2D ). Phosphorylation was also detected in S359, although the signal was not as robust or consistent compared to T360 or Y361, perhaps due to steric hindrance from a nearby a helix structure as predicted by the Phyre (A) Experimental procedures using in vitro kinase assays and liquid chromatography-tandem mass spectrometry (LC-MS/MS) to characterize HIPK2 phosphorylation.
(B and C) Protein lysates from HEK293 cells treated with tunicamycin were used for in vitro kinase assays to detect HIPK2 activation measured by incorporation of g-P 32 -ATP and to detect p-ASK1 and p-JNK.
(D) (Top) Representative LC-MS/MS spectrum of a singly phosphorylated HIPK2 tryptic peptide spanning the S359, T360, and Y361 residues shows overlapping ion series corresponding to phosphorylation at T360 and Y361, highlighted in blue and green, respectively. All assigned ion peaks are marked in red. (Bottom) Relative phosphorylation of HIPK2 at the two sites with and without tunicamycin treatment was compared by calculating peak areas of extracted ion chromatographs.
(E) Protein lysates from HEK293 cells expressing HIPK2-WT, HIPK2-S359A, HIPK2-T360A, or HIPK2-Y361F were used in in vitro kinase assays to detect g-P 32 -ATP incorporation in HIPK2 after tunicamycin treatment.
(F) HEK293 cells expressing HIPK2-WT, HIPK2-S359A, HIPK2-T360A, and HIPK2 kinase-dead HIPK2-K221A were treated with tunicamycin. Cell viability was measured using MTT assay. Two-way ANOVA, *p < 0.05. 2009). To investigate how phosphorylation of these residues affects ER stress, we introduced point mutations in HIPK2 on S359 (HIPK2-S359A), T360 (HIPK2-T360A), and Y361 (HIPK2-Y361F) and used in vitro kinase assays to determine whether mutations in these amino acids affected the ability of HIPK2 to incorporate g-P 32 -ATP. Surprisingly, tunicamycin-induced g-P 32 -ATP incorporation in HIPK2 was not affected in HIPK2-Y361F but was drastically decreased in HIPK2-T360A and HIPK2-S359A (Figure 2E ). These results validate the essential role of T360 and S359 in ER-stress-induced HIPK2 phosphorylation and suggest that ER stress may induce HIPK2 phosphorylation that begins either simultaneously or sequentially at T360 and S359 to promote HIPK2 activation ( Figure 2N ). In contrast, loss of phosphorylation at the Y361 is not required for HIPK2 activation under ER stress.
To characterize how HIPK2 phosphorylation might affect cellular response to ER stress, we expressed wild-type HIPK2 (HIPK2-WT), HIPK2-S359A, HIPK2-T360A, or HIPK2-Y361F in HEK293 cells and treated these cells with tunicamycin. Both HIPK2-WT and HIPK2-Y361F promoted cell death in tunicamycin-treated HEK293 cells. In contrast, HIPK2-S359A and HIPK2-T360A protected cells from tunicamycin-induced cell death with similar efficiency ( Figure 2F ). Interestingly, the protective effects of HIPK2-S359A and HIPK2-T360A expression were similar to that of kinase-dead HIPK2-K221A mutant, supporting the idea that HIPK2 phosphorylation on S359/T360 might be coupled to HIPK2 kinase activation. To further characterize the role of HIPK2 phosphorylation in ER stress, we generated antibodies that recognized phosphorylated S359 and T360 residues in HIPK2. This epitope-specific HIPK2 antibody (hereafter named p-HIPK2 [S359/T360] Ab) detected no HIPK2 phosphorylation in untreated cells. Upon tunicamycin treatment, however, p-HIPK2 [S359/T360] Ab detected an increase in phosphorylated HIPK2 with kinetics similar to those revealed by in vitro kinase assays ( Figure 2G ). In addition, p-HIPK2 [S359/T360] Ab detected phosphorylated HIPK2 in brain tissues from tunicamycin-treated wild-type mice, but not Hipk2 À/À mice ( Figure S3D ), supporting the specificity of this antibody.
HIPK2 Acts Downstream of ASK1 and Upstream of JNK during ER Stress
The sequential activation of ASK1, HIPK2, and JNK in response to ER stress raised the possibility that ASK1 may activate HIPK2 by phosphorylating S359 and T360, which then activates HIPK2 kinase activity and promotes JNK activation. To further delineate the relationship between ASK1, HIPK2, and JNK during ER stress, we expressed a series of HIPK2 deletion mutants in HEK293 cells and used co-immunoprecipitation to detect the interaction between HIPK2 and endogenous ASK1 after tunicamycin treatment. These results showed that removing the domain between amino acids 583 and 798 (HIPK2
D583-798
) completely abolished HIPK2-ASK1 interaction ( Figure S4A ), whereas overexpressing ASK1 promoted phosphorylation in wild-type HIPK2, but not HIPK2 D583-798 ( Figure S4B ). We then used siRNA to knock down ASK1 in HEK293 cells, which resulted in a near-complete loss of tunicamycin-induced HIPK2-S359/T360 phosphorylation ( Figure 2H ). In contrast, overexpression of ASK1 enhanced S359/T360 phosphorylation in wild-type HIPK2 and kinase-dead mutant HIPK2-K221A, but not in HIPK2-S359A ( Figure 2I ). These results suggest that S359/T360 phosphorylation in HIPK2 precedes HIPK2 kinase activation during ER stress and that both are required for HIPK2 activation and its ability to promote the downstream cell death pathway.
To characterize the role of HIPK2 in ER-stress-induced JNK activation, we performed co-immunoprecipitation using protein lysates from HEK293 cells expressing GFP-tagged HIPK2 and HA-tagged JNK2 and showed that tunicamycin induced a robust, time-dependent increase in protein complex formation between HIPK2 and JNK2 ( Figure 2J ). The protein complex formation between HIPK2 and JNK2 was significantly reduced in HIPK2 kinase-dead mutant and almost completely abolished in HIPK2
D583-798 ( Figure 2K ). Interestingly, acute knockdown of endogenous HIPK2 using siRNA in HEK293 cells resulted in reduced JNK activation in response to tunicamycin without affecting ASK1 activation ( Figure 2L ), consistent with ASK1 acting upstream of HIPK2. In addition, overexpression of HIPK2-S359A and HIPK2-T360A, but not HIPK2-Y361F, blocked JNK activation in response to tunicamycin treatment ( Figure 2M ), suggesting that HIPK2 phosphorylation at S359/T360 is required to promote ER-stress-induced JNK activation. Finally, Hipk2 ;Jnk2 À/À MEF cells ( Figure S5C ). Collectively, these results suggest that ER stress activates a cascade of signaling events, including ASK1-mediated phosphorylation of HIPK2 on S359/T360, which cooperatively activates HIPK2 kinase and HIPK2-JNK complex formation to promote cell death ( Figure 2N ).
HIPK2 Promotes JNK Activation and Neuronal Cell
Death in SOD1 G93A Mice Previous studies indicate that the accumulation of misfolded mutant SOD1
G93A proteins activate UPRs that contribute to neurodegeneration (Atkin et al., 2006; Nishitoh et al., 2008) . To ask whether HIPK2 activation might promote neurodegeneration in this model, we used immunofluorescent microscopy with anti-HIPK2 antibody and showed that HIPK2 protein was expressed at low levels in wild-type spinal motor neurons at postnatal day (P) 90 ( Figures 3A-3D, arrowheads) . In contrast, spinal motor neurons in SOD1 G93A littermates showed a significant increase in HIPK2 expression ( Figures 3E-3H, arrowheads) . Importantly, spinal motor neurons in SOD1 G93A mice with higher HIPK2 expression also showed prominent accumulation of misfolded SOD1 G93A proteins, detected by conformation-specific C4F6 antibody (Bosco et al., 2010) (Figures 3E-3H, arrow) . Furthermore, HIPK2 protein signal intensity in spinal motor neurons in SOD1 G93A mice showed an age-dependent increase that correlated with relative abundance of misfolded SOD1 G93A proteins ( Figure 3I ).
To investigate whether HIPK2 was activated as disease progressed in SOD1 G93A mice, we used immunoprecipitationin vitro kinase (IP-IVK) assays and showed that HIPK2 proteins in SOD1 G93A mice exhibited a marked increase in g-P
32
-ATP incorporation at P60 and P90 (Figures 3J and 3K) . Consistent with these results, HIPK2 [S359/T360] antibody also detected a progressive increase in phosphorylated HIPK2 in the spinal cord tissues of SOD1 G93A mice ( Figure 3J ). Similar to HIPK2, phosphorylation of IRE1a, ASK1, and JNK, as well as splicing of Xbp1 mRNA were all concurrently upregulated in the spinal cord of SOD1 G93A mice (Figures 3J and 3K ). These results show that ER stress activation precedes disease onset and becomes more severe as disease progresses in SOD1 G93A mice.
To further characterize the role of HIPK2 in ALS, we used western blots and showed that the activation of IRE1a-HIPK2-JNK pathway was indeed much more robust in spinal cord tissues from three FALS cases with mutations in the SOD1 gene (SOD1
A4V
, SOD1 D125V and SOD1 A4T ) (Figures 3L-3M ; Table   S1 ). Furthermore, we developed two-color immunostains for HIPK2 and misfolded SOD1 proteins and showed that spinal motor neurons in five patients with SOD1 mutations, including SOD1 A4T , SOD1 G93A , SOD1 I133T , SOD1 E100G , and SOD1 V14M , contained prominent misfolded SOD1 mutant proteins in the cytoplasm (brown color) and $2-fold increase in HIPK2 immunoreactivity in the nucleus (blue color) ( Figures 3P-3R , arrowheads). In contrast, control motor neurons showed very low level of HIPK2 proteins in the nucleus and no detectable misfolded SOD1 proteins in the cytoplasm ( Figures 3N-3O Figure 3S ). mice showed an age-dependent progressive increase in astrogliosis and microgliosis in the spinal cord, both were significantly reduced in SOD1 G93A ;Hipk2 À/À mice ( Figures 4G-4L and 4N ).
Loss of HIPK2 Attenuates Neurodegeneration in
Because Hipk2 À/À mice were maintained in B6;129 background and SOD1 G93A mice were in B6;SJL background, the mating between these two mouse lines generated progenies with a mixed genetic background (B6SJL 3 B6;129), which slightly affected disease onset and survival curves compared with SOD1 G93A in B6:SJL background (Gurney et al., 1994 Figure 4P ). Together, these results indicate that loss of HIPK2 significantly attenuates neurodegeneration in SOD1 G93A mice.
ER Stress and HIPK2 Activation in TDP-43, but Not FUS, ALS Model
To determine whether ER stress is also a prominent disease mechanism shared among other mouse ALS models, we characterized the state of IRE1a-HIPK2-JNK activation in FUS-R521C mice that express the most common human FUS mutation FUS-R521C and the bi-transgenic, tetracycline-inducible NEFH-tTA/tetO-hTDP-43DNLS mice that express truncated human TDP-43 lacking the nuclear localization signal (Qiu et al., 2014; Walker et al., 2015) . In our previous studies, we show that $60% of FUS-R521C transgenic mice develop ALS-like symptoms before P90 due to severe dendritic and synaptic defects (Qiu et al., 2014) , whereas removing doxycycline from the drinking water for NEFH-tTA/tetO-hTDP-43DNLS mice induces progressive ALS-like symptoms with accumulation of soluble and insoluble hTDP-43DNLS proteins in the cytoplasm of cortical and spinal motor neurons (Walker et al., 2015) . Unlike SOD1 G93A mice, FUS-R521C mice that reached end-stage disease at P90 showed no evidence of activation in IRE1a, HIPK2, or JNK ( Figures 5A and 5B ). In contrast, expressing hTDP-43DNLS in NEFH-tTA/tetO-hTDP-43DNLS mice led to a progressive increase in p-IRE1a, p-HIPK2 [S359/T360], and p-JNK that reached its maximum at 11 weeks after induction ( Figures 5C and 5D) . Consistent with the western blot results, spinal motor neurons in NEFH-tTA/tetO-hTDP-43DNLS mice showed a significant increase in HIPK2 proteins 10 weeks after induced expression of hTDP-43DNLS (Figures 5E-5K) . Together, these results identify ER stress and IRE1a-HIPK2-JNK pathway as a common disease mechanism shared by SOD1 G93A and NEFH-tTA/tetO-hTDP-43DNLS mice, but not FUS-R521C mice.
HIPK2 Activation Correlates with TDP-43 Proteinopathy in SALS and C9-ALS
Given the results from tunicamycin-induced ER stress, SOD1
G93A
, and NEFH-tTA/tetO-hTDP-43DNLS mouse models, we reasoned that the activation of HIPK2-JNK pathway may have a broader role in the pathogenesis of ALS. Since TDP-43 protein misfolding and aggregation is a common pathological feature in SALS and C9-ALS (Brettschneider et al., 2014; Mackenzie et al., 2014) , we asked whether misfolded TDP-43 proteins might trigger ER stress and HIPK2 activation to promote disease initiation and progression. To test this, we prepared protein lysates from the spinal cord of 28 cases of SALS and 16 cases of C9-ALS using published protocols (Neumann et al., 2006) . In addition, we also prepared 13 spinal cord and 10 frontal cortex samples from cases with no history of neurodegenerative disease, and samples from the frontal cortex of seven cases with Alzheimer's disease (Table S1) .
We Figures  6J-6L ). Consistent with these results, the remaining spinal motor neurons in SALS and C9-ALS cases showed a robust increase in HIPK2 protein levels by immunostaining (Figures 6M-6P ). In contrast, samples from the frontal cortex of Alzheimer's disease G93A , and SOD1
;Hipk2 À/À mice at P90 and P120.
(G-L) Immunostaining for GFAP+ astrocytes and Iba1+ microglia in wild-type, SOD1 G93A , and SOD1
;Hipk2 À/À mice at P120.
(M and N) Number of ChAT+ motor neurons, GFAP+ astrocytes, and Iba1+ microglia in wild-type; SOD1
; and SOD1
;Hipk2 À/À mice at P90 and P120. , and SOD1
;Hipk2 À/À mice. Two-way ANOVA, *p = 0.04, **p = 0.0082, ***p = 0.002; ns, not significant.
cases showed no evidence of TDP-43 proteinopathy or HIPK2 phosphorylation ( Figure S8 ).
HIPK2 Kinase Inhibitors Attenuate Cytotoxicity from
Tunicamycin, SOD1 G93A and TDP-43 in Spinal Motor Neurons To determine the effects of HIPK2 kinase inhibitors in blocking ER-stress-induced cell death, we used tunicamycin and SOD1
G93A
-induced cell death as models to screen a number of HIPK2 kinase inhibitors (Miduturu et al., 2011) . Of the five HIPK2 kinase inhibitors screened (Table S2 ), A64 and JWD-065 showed the most robust effects in blocking HIPK2 phosphorylation on S359/T360 and JNK activation in HEK293 cells ( Figures 7A and 7B) , blocking tunicamycin-induced cell death with an EC 50 of 0.403 mM and 0.641 mM, respectively (Figures 7C). Western blots and immunostaining for activated caspase 3 also showed that A64 blocked p-HIPK2 [S359/T360] in primary spinal motor neurons and protected >60% of these neurons from tunicamycin-and SOD1
-induced cell death (Figures 7D-7L ). To determine whether HIPK2 inhibitors can also protect neurons from cytotoxicity from TDP-43 proteinopathy, we trans- Figures 8D, 8E, 8G , and 8I). In contrast, A64 treatment protected neurons from cell death induced by either wild-type or mutant TDP-43 ( Figures 8F, 8H, and 8I ). , FUS-R521C, and wild-type littermates were used in western blots to compare the levels of p-IRE1a, p-HIPK2 [S359/ T360], and p-JNK. Student's t test, *p < 0.05 and **p < 0.01. (C and D) RIPA soluble lysates are prepared from the cortex non-transgenic control (nTg), NEFH-tTA mice (tTA), and NEFH-tTA/tetO-hTDP-43DNLS mice that are ''off doxycycline'' for 1, 2, 4, 6, 7, 11, and 15 weeks to detect activated and total IRE1a, HIPK2, and JNK. Two-tailed unpaired Student's t test; *p < 0.05, **p < 0.01. (E-K) Confocal images of HIPK2 in ChAT+ motor neurons in NEFH-tTA mice and NEFH-tTA/tetO-hTDP-43DNLS (rNLS8) mice that are ''off doxycycline'' for 10 weeks. Arrows indicate ChAT+ neurons, and arrowheads indicate ChATÀ neurons. Relative signal intensity of HIPK2 was quantified by NIH ImageJ. Twotailed unpaired Student's t test, ***p < 0.001.
These results support that HIPK2 activation promotes cell death, whereas blocking HIPK2 may mitigate neurodegeneration, caused by TDP-43 proteinopathy.
DISCUSSION
HIPK2 Activation Links Persistent ER Stress to Cell Death
Chronic ER stress contributes to many human diseases, including diabetes, viral infections, cancer, and neurodegeneration (Kim et al., 2008; Oakes and Papa, 2015) . Indeed, several studies indicate that misfolded mutant SOD1 proteins can robustly activate adaptive UPR, including activation of ASK1 and PERK, Xbp1 mRNA splicing, and transcriptional upregulation of protein chaperone machinery (Walker and Atkin, 2011 ). These studies demonstrate that PERK activation and upregulation of ER chaperones and members of the protein disulfide isomerase (PDI) family alleviate neurodegeneration. Similarly, removal of XBP1 or ASK1 prolongs survival of SOD1 G93A mice (Hetz et al., 2009; Nishitoh et al., 2008) . The implications of ER stress activation in the pathogenesis of ALS have been further supported by the findings that autosomal dominant mutations in the human ALS8 gene, VAPB, can potentiate ER stress response-mediated cell death (Suzuki et al., 2009) . Collectively, these results support the conceptual framework that disruption of the homeostatic control of ER stress is critical to the pathophysiology and disease progression in ALS.
Despite the important role of ER stress in ALS, it remains unclear what dictates the decision between survival and cell death during ER stress response. The resistance of Hipk2 À/À neurons to tunicamycin-induced cell death implicates HIPK2 as the key mediator of ASK1-JNK pro-apoptotic pathway during persistent ER stress response (Figures 1 and S1) . The mechanism by which ER stress activates HIPK2 involves epitope-specific phosphorylation of S359/T360 residues within the activation loop of HIPK2 kinase domain, which activates HIPK2 kinase activity and promotes HIPK2-JNK protein complex formation (Figure 2) . Not only do these results solidify the evidence that HIPK2 links ER stress to pro-apoptotic JNK activation (Oakes and Papa, 2015; Ron and Walter, 2007) , they also open up new opportunities to interrogate the state of ER stress response in a pathway-specific fashion. Indeed, using Xbp1 mRNA splicing and epitope-specific p-IRE1a, p-ASK1, p-HIPK2 [S359/T360], and p-JNK antibodies, we show that the pathway downstream of IRE1a is robustly upregulated in the spinal cord of SOD1 G93A mice as early as P60 when these mice are free of any neurological symptoms (Figure 3) . Interestingly, loss of HIPK2 selectively blocks JNK activation without affecting Xbp1 splicing or the activation of IRE1a and ASK1 ( Figures 3S and 3T) . Moreover, loss of HIPK2 reduces neuronal cell death and attenuates neurodegeneration in SOD1 G93A mice (Figures 3 and 4) . These results place HIPK2 downstream of IRE1a and ASK1 in the ER stress pathway and underscore the specific role of HIPK2 in promoting neuronal cell death under ER stress conditions.
ER Stress and Mechanisms of Neurodegeneration in ALS
Neuropathological examination of the majority of SALS and C9-ALS cases has shown that TDP-43 proteinopathies, characterized by ubiquitination and phosphorylation of TDP-43, are key diagnostic features associated with both diseases. These results suggest that TDP-43 protein misfolding might induce ER stress response and thereby contribute to the pathogenesis of SALS and C9-ALS. In support of this, ER stress response has been reported in a small number of sporadic ALS cases and ALS-associated TDP-43 mutations can increase sensitivity to ER stress and induce XBP1 nuclear translocation (Atkin et al., 2008; Walker et al., 2013) . One intriguing observation from our study is the lack of ER stress or HIPK2 activation in the FUS-R521C transgenic mouse model. Consistent with these results, histopathology and RNA-seq analyses in FUS-R521C mice show robust defects in RNA transcription/splicing and DNA damage repair, but no significant increase in ER stress response (Qiu et al., 2014) . These results underscore the divergent role of ER-stress-induced neurodegeneration in the pathogenesis of different subtypes of ALS. ] and p-JNK. Two-tailed unpaired Student's t test; *p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.0001. (C) HEK293 cells were treated with tunicamycin (1 mg/ml) and HIPK2 inhibitors at the designated concentrations. Cell viability is determined using MTT assays. Two-way ANOVA; **p < 0.01 and ***p < 0.005. (D) Motor neurons were treated with DMSO, tunicamycin (1 mg/ml), or tunicamycin and HIPK2 inhibitor A64 (1 mM). Protein lysates from these neurons were used to characterize HIPK2 and JNK phosphorylation. (E-J) Cortical neurons were treated with DMSO, tunicamycin (1 mg/ml), or tunicamycin and HIPK2 inhibitor A64 (1 mM). Cell death was analyzed using antibodies for activated caspase 3. (K) Quantificaiton of caspase 3+ neurons. Data represents mean ± SEM. Two-tailed unpaired Student's t test; *p < 0.05. (L) Motor neurons transfected with mutant SOD1 G93A were treated with HIPK2 inhibitor A64, and cell death quantified using activated caspase 3 antibody.
How does ER stress contribute to the pathogenesis and disease progression in C9-ALS? Several recent studies provide important insights into the mechanisms that may contribute to ER stress in C9-ALS. First, it has been shown that the accumulation of dipeptide repeat proteins, encoded by the mRNA from C9orf72 hexanucleotide expansion via repeat associated non-ATG (RAN) translation, can induce ER stress and TDP-43 proteinopathy (Chew et al., 2015; Zhang et al., 2014) . Second, neurons derived from C9-ALS patients show a marked increase of cell death upon tunicamycin treatment, suggesting that these neurons are much more vulnerable to ER stress (Haeusler et al., 2014) . Finally, two recent studies show that C9orf72 mutations can also disrupt nucleocytoplasmic transport proteins, such as RanGAP (Freibaum et al., 2015; Zhang et al., 2015) . These results raise the possibility that defects in the nucleocytoplasmic transport machinery may impair nuclear import of RNA binding proteins, such as TDP-43, leading to cytoplasmic accumulation of TDP-43 to trigger ER stress.
Unlike the recent advances in the C9-ALS disease mechanisms, much less is known about the relationship between ER stress and TDP-43 accumulation in SALS. By quantifying the relative abundance of p-HIPK2 [S359/T360] and p-JNK in a large number of sporadic ALS and C9-ALS cases, we demonstrate that HIPK2 and JNK activation are tightly coupled in disease and positively correlate with TDP-43 proteinopathy (Figure 6 ). In addition, these cases show robust activation of p-IRE1a and p-ASK1 (S.L., unpublished data), again supporting the idea that the entire ASK1-HIPK2-JNK pathway is activated in human ALS. Finally, similar to SOD1 G93A mice and FALS patients with SOD1 mutations (Figure 3 ), many remaining spinal motor neurons in sporadic ALS and C9-ALS cases continue to show robust accumulation of HIPK2 in the nucleus (Figure 6 ). These results support the hypothesis that the pro-apoptotic ER stress pathway, involving ASK1, HIPK2, and JNK, is a prominent feature conserved in sporadic and familial ALS.
HIPK2 Activation as a Therapeutic Target and Biomarker for ALS
The prominent role of HIPK2 activation in ER-stress-induced cell death raises the possibility that HIPK2 might be a feasible therapeutic target for ALS. This is supported by the results that HIPK2-S359A, HIPK2-T360A, and kinase-dead HIPK2-K221A can mitigate tunicamycin-induced JNK activation and cell death in HEK293 cells (Figure 2 ). In addition, loss of HIPK2 attenuates neurodegenerative phenotypes in SOD1 G93A mice (Figure 4 ). Furthermore, HIPK2 inhibitor A64 protects cytotoxicity caused by tunicamycin, SOD1
G93A , and overexpression of wild-type or mutant TDP-43 (Figures 7 and 8) . Thus, the broad benefits of blocking HIPK2 activation in these conditions provide affirmative evidence that inhibition of HIPK2 kinase can protect neurons from ER stress-induced cell death in ALS. By analyzing a single dominant pro-apoptotic pathway in the ER stress response, we reveal a robust and positive correlation between HIPK2-JNK activation and TDP-43 proteinopathy in a large number of sporadic ALS and C9-ALS cases. However, these results also reveal significant heterogeneity in the magnitude of HIPK2-JNK activation in ALS patients. Such heterogeneity most likely reflects the stage of disease, the number of remaining neurons with TDP-43 inclusions, and/or other complex and diverse pathogenic factors that contribute to the chronic loss of motor neurons via cell autonomous and noncell-autonomous mechanisms. Given the robust correlation between HIPK2 activation and TDP-43 proteinopathy, it is tempting to speculate that this correlation may serve as an important biomarker to (1) stratify ALS patients based on the magnitude of intrinsic ER stress response and (2) identify patients that are most likely to benefit from intervention using HIPK2 inhibitors. In addition, HIPK2-JNK activation may also serve as a pharmacodynamic indicator to monitor the treatment efficacy of blocking the ER stress response or as a prognostic indicator of disease progression and recurrence.
EXPERIMENTAL PROCEDURES Animals
Hipk2
À/À (RRID: MGI_5008273, MGI_3510466), SOD1 G93A mice (RRID: MGI_3785391), FUS-R521C mice (JAX Stock #026406), and NEFH-tTA/tetOhTDP-43DNLS (rNLS8) mice (JAX Stock #028412) have been previously described (Gurney et al., 1994; Qiu et al., 2014; Walker et al., 2015; Wiggins et al., 2004) . Animal care was approved by the Institutional of Animal Care and Use Committee (IACUC) and followed the National Institute of Health guidelines.
Human Brain and Spinal Cord Tissues
Frozen and paraffin-embedded spinal cord tissues were procured from controls with no known neurodegenerative diseases, SALS patients, and FALS patients with SOD1 or C9ORF72 mutations. Frozen tissues from frontal cortex were obtained from controls and patients with Alzheimer's disease. All cases were evaluated at the University of California San Francisco, University of Pennsylvania, and Northwestern University, and tissues were collected with informed consents and institutional IRB approvals. Demographic information and clinical data of these cases are provided in Table S1 .
HIPK2 Kinase Inhibitors
HIPK2 kinase inhibitors, A64, B28, and CP466722, were reported previously (Miduturu et al., 2011; Rainey et al., 2008) , whereas CVM-05-145-3 and JWD-065 have not been published. The structure these inhibitors, their Simplified Molecular-Input Line-Entry System (SMILES) information, and EC 50 to suppress tunicamycin-induced cell death are provided in Table S2 . 
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